TSN084

· Tyligand Bioscience (Shanghai) Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TSN084, covering 2024-06-25 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: TSN084 Treating Patients With Advanced Malignant Tumors [Phase 1]